Anke Richters
About
Anke Richters is a scholar working on Surgery, Oncology and General Health Professions.
According to data from OpenAlex, Anke Richters has authored 36 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Oncology and 6 papers in General Health Professions. Recurrent topics in Anke Richters's work include Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (12 papers) and Geriatric Care and Nursing Homes (5 papers). Anke Richters is often cited by papers focused on Bladder and Urothelial Cancer Treatments (14 papers), Urinary and Genital Oncology Studies (12 papers) and Geriatric Care and Nursing Homes (5 papers). Anke Richters collaborates with scholars based in Netherlands, Germany and Switzerland. Anke Richters's co-authors include Lambertus A. Kiemeney, Katja K.H. Aben, Saurabh Zalpuri, Maurice P. Zeegers, Bart G. Pijls, Stevie Hendriks, Shahab Jolani, Antoine G. van der Heijden, Anique Atherley and Gregor H. L. M. Franssen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of the American Geriatrics Society.
In The Last Decade
Anke Richters
33 papers receiving 1.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Anke Richters Netherlands | 13 | 577 | 365 | 363 | 253 | 236 | 36 | 1.5k | ||
| Karen L. Smith United States | 21 | 204 0.4× | 269 0.7× | 570 1.6× | 214 0.8× | 264 1.1× | 81 | 2.5k | ||
| Wen Zeng China | 23 | 248 0.4× | 335 0.9× | 245 0.7× | 459 1.8× | 114 0.5× | 132 | 1.7k | ||
| Liang Hong China | 16 | 558 1.0× | 352 1.0× | 218 0.6× | 685 2.7× | 109 0.5× | 45 | 1.9k | ||
| James W. Antoon United States | 26 | 139 0.2× | 678 1.9× | 277 0.8× | 187 0.7× | 175 0.7× | 96 | 1.7k | ||
| Lucas Faria Abrahão‐Machado Brazil | 12 | 121 0.2× | 193 0.5× | 291 0.8× | 193 0.8× | 284 1.2× | 28 | 940 | ||
| Anand Sharma United Kingdom | 17 | 372 0.6× | 251 0.7× | 197 0.5× | 47 0.2× | 168 0.7× | 92 | 1.1k | ||
| Mojgan Karimi‐Zarchi Iran | 23 | 289 0.5× | 196 0.5× | 423 1.2× | 85 0.3× | 110 0.5× | 138 | 1.9k | ||
| Samuel Ariad Israel | 21 | 123 0.2× | 256 0.7× | 781 2.2× | 129 0.5× | 181 0.8× | 109 | 1.5k | ||
| İskender Sayek Türkiye | 25 | 1.4k 2.4× | 210 0.6× | 236 0.7× | 402 1.6× | 376 1.6× | 102 | 2.7k |
Countries citing papers authored by Anke Richters
Since
Specialization
Citations
This map shows the geographic impact of Anke Richters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Richters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Richters more than expected).
Fields of papers citing papers by Anke Richters
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Anke Richters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Richters. The network helps show where Anke Richters may publish in the future.
Co-authorship network of co-authors of Anke Richters
This figure shows the co-authorship network connecting the top 25 collaborators of Anke Richters. A scholar is included among the top collaborators of Anke Richters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anke Richters. Anke Richters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Richters, Anke, Heidi P. Fransen, Tineke J. Smilde, et al.. (2024). Guidelines versus real-world data in metastatic bladder cancer: A population-based study on first-line chemotherapy treatment patterns. Urologic Oncology Seminars and Original Investigations. 43(5). 328.e17–328.e24.
2.
Bosveld, J., Tri Q. Nguyen, Joost L. Boormans, et al.. (2024). The impact of positive surgical margins after cystectomy on oncological outcomes: a nationwide study. British Journal of Urology. 135(5). 766–774.
3.
Özdemir, Berna C., Anke Richters, Sabine Oertelt‐Prigione, et al.. (2024). 1592P Awareness and interest of oncology professionals in sex and gender differences in cancer risk and outcome: Analysis of an ESMO Gender Medicine Task Force survey. Annals of Oncology. 35. S959–S959.
4.
Hoogstraten, Lisa M.C. van, Alina Vrieling, Antoine G. van der Heijden, et al.. (2023). Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice. Nature Reviews Clinical Oncology. 20(5). 287–304.
5.
Özdemir, Berna C., et al.. (2023). Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research. iScience. 26(4). 106212–106212.
6.
Liu, Michael, et al.. (2023). Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease. Oncology Letters. 26(3). 377–377.
7.
Richters, Anke, Debbie Robbrecht, Richard P. Meijer, et al.. (2023). Treatment Patterns and Use of Immune Checkpoint Inhibitors Among Patients with Metastatic Bladder Cancer in a Dutch Nationwide Cohort. European Urology Open Science. 59. 50–54.
8.
Richters, Anke, et al.. (2023). Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers. JAMA Oncology. 9(8). 1144–1144.
9.
Richters, Anke, et al.. (2022). Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer Registry. World Journal of Urology. 40(9). 2275–2281.
10.
Richters, Anke, Joost L. Boormans, Michiel S. van der Heijden, et al.. (2021). Overall survival of patients receiving cisplatin or carboplatin for primary metastatic urothelial carcinoma of the bladder: A contemporary Dutch nationwide cohort study. European Urology Open Science. 33. S391–S391.
11.
Richters, Anke, Richard P. Meijer, Niven Mehra, et al.. (2021). Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI. BMJ Open. 11(5). e047256–e047256.
12.
Pijls, Bart G., Shahab Jolani, Anique Atherley, et al.. (2021). Demographic risk factors for COVID-19 infection, severity, ICU admission and death: a meta-analysis of 59 studies. BMJ Open. 11(1). e044640–e044640.
13.
Richters, Anke, Lambertus A. Kiemeney, Niven Mehra, et al.. (2021). Evidence or Prejudice? Critical Re-Analysis of Randomized Controlled Trials Comparing Overall Survival After Cisplatin Versus Carboplatin-Based Regimens in Advanced Urothelial Carcinoma. Clinical Genitourinary Cancer. 20(4). e346–e352.
14.
Richters, Anke, Joost L. Boormans, Michiel S. van der Heijden, et al.. (2021). Overall Survival of Patients Receiving Cisplatin or Carboplatin for Primary Metastatic Urothelial Carcinoma of the Bladder: A Contemporary Dutch Nationwide Cohort Study. European Urology Focus. 8(4). 995–1002.
15.
Richters, Anke, Niven Mehra, Richard P. Meijer, et al.. (2020). Utilization of systemic treatment for metastatic bladder cancer in everyday practice: Results of a nation-wide population-based cohort study. Cancer Treatment and Research Communications. 25. 100266–100266.
16.
Richters, Anke, et al.. (2017). Triple aim improvement for individuals, services and society in dementia care. Zeitschrift für Gerontologie und Geriatrie. 50(S2). 78–83.
17.
Richters, Anke, René J. F. Melis, Job van Exel, Marcel G. M. Olde Rikkert, & Marjolein A. van der Marck. (2017). Perseverance time of informal caregivers for people with dementia: construct validity, responsiveness and predictive validity. Alzheimer s Research & Therapy. 9(1). 26–26.
18.
Richters, Anke, Olga Husson, L. Fossion, et al.. (2014). Effect of surgical margin status after radical prostatectomy on health-related quality of life and illness perception in patients with prostate cancer. Urologic Oncology Seminars and Original Investigations. 33(1). 16.e9–16.e15.
19.
Fehse, Boris, Anke Richters, Hannes Klump, et al.. (2000). CD34 Splice Variant: An Attractive Marker for Selection of Gene-Modified Cells. Molecular Therapy. 1(5). 448–456.
20.
Hunt, Nicholas H., Markus Hildinger, Hans‐Georg Eckert, et al.. (1998). Cis-Active Elements of Friend Spleen Focus-Forming Virus: From Disease Induction to Disease Prevention. Acta Haematologica. 99(3). 156–164.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Karen L. Smith Breakdown of academic impact, for papers by Wen Zeng Breakdown of academic impact, for papers by Liang Hong Breakdown of academic impact, for papers by James W. Antoon Breakdown of academic impact, for papers by Lucas Faria Abrahão‐Machado Breakdown of academic impact, for papers by Anand Sharma Breakdown of academic impact, for papers by Mojgan Karimi‐Zarchi Breakdown of academic impact, for papers by Samuel Ariad Breakdown of academic impact, for papers by İskender Sayek